- Home
- CRVS vs CLPT Comparison
CRVS vs CLPT Comparison
Compare CRVS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- CLPT
- Stock Information
- Founded
- CRVS 2014
- CLPT 1998
- Country
- CRVS United States
- CLPT United States
- Employees
- CRVS N/A
- CLPT N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- CRVS Health Care
- CLPT Health Care
- Exchange
- CRVS Nasdaq
- CLPT Nasdaq
- Market Cap
- CRVS 305.4M
- CLPT 317.4M
- IPO Year
- CRVS 2016
- CLPT N/A
- Fundamental
- Price
- CRVS $5.75
- CLPT $10.49
- Analyst Decision
- CRVS Strong Buy
- CLPT Strong Buy
- Analyst Count
- CRVS 4
- CLPT 3
- Target Price
- CRVS $15.00
- CLPT $27.67
- AVG Volume (30 Days)
- CRVS 518.7K
- CLPT 375.5K
- Earning Date
- CRVS 08-07-2025
- CLPT 08-12-2025
- Dividend Yield
- CRVS N/A
- CLPT N/A
- EPS Growth
- CRVS N/A
- CLPT N/A
- EPS
- CRVS N/A
- CLPT N/A
- Revenue
- CRVS N/A
- CLPT $33,593,000.00
- Revenue This Year
- CRVS N/A
- CLPT $22.34
- Revenue Next Year
- CRVS N/A
- CLPT $25.50
- P/E Ratio
- CRVS N/A
- CLPT N/A
- Revenue Growth
- CRVS N/A
- CLPT 19.68
- 52 Week Low
- CRVS $2.54
- CLPT $9.76
- 52 Week High
- CRVS $10.00
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- CLPT 44.46
- Support Level
- CRVS $5.28
- CLPT $10.42
- Resistance Level
- CRVS $5.64
- CLPT $10.88
- Average True Range (ATR)
- CRVS 0.30
- CLPT 0.52
- MACD
- CRVS 0.03
- CLPT -0.01
- Stochastic Oscillator
- CRVS 77.70
- CLPT 22.75
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.